Hair loss during GLP-1 treatment: causes and assessment
Hair loss during treatment has several possible causes. Reduced intake and rapid weight change can contribute, but the medication labels also report hair loss; it should not be dismissed automatically.
GLP-1 Brands & Reviews
- #1
CoreAge Rx
Editorial score: 9.8/10
CoreAge Rx offers clinician-reviewed compounded weight care. Compare the annual offer from $79/month for semaglutide or $129/month for tirzepatide with the full payment, dispensing details and refund conditions.
Semaglutide from $79/mo · Tirzepatide from $129/mo
Published
- Online prescribing and pharmacy fulfillment
- Dated first-party sources in the review
Questions to resolve
- Confirm full medication and care cost
- Verify local eligibility and ongoing support
- #2
SuperHealthy Rx
Editorial score: 9.6/10
SuperHealthy Rx advertises compounded semaglutide at $85/month and tirzepatide at $135/month, with a provider visit and shipping included. Confirm the current offer, billing term and state eligibility.
Semaglutide: $85/month advertised · Tirzepatide: $135/month advertised
Published
- Online prescribing and pharmacy fulfillment
- Dated first-party sources in the review
Questions to resolve
- Confirm full medication and care cost
- Verify local eligibility and ongoing support
- #3
Likeness Rx
Editorial score: 9.4/10
Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
Semaglutide from $79/month · Tirzepatide from $129/month
Published
- Online prescribing and pharmacy fulfillment
- Dated first-party sources in the review
Questions to resolve
- Confirm full medication and care cost
- Verify local eligibility and ongoing support
- #4
Henry Meds
Editorial score: 9.3/10
Henry describes cash-pay plans bundling visits, medicine, supplies and ongoing care. Its multi-month cancellation terms can differ from its monthly plans.
Complete current quote needed
Published
- Telehealth and weight care
- Dated first-party sources in the review
Questions to resolve
- Confirm full medication and care cost
- Verify local eligibility and ongoing support
- #5
Hims
Editorial score: 9.1/10
Hims currently publishes a weight-loss membership with approved product options and medication billed separately. Older compounded-only descriptions do not capture its current offer.
Membership, medicine extra
Published
- Telehealth and weight care
- Dated first-party sources in the review
Questions to resolve
- Confirm full medication and care cost
- Verify local eligibility and ongoing support
Publisher preference scores. Comparison method and commercial relationships.
At a glance
- Describe the pattern and timing to a clinician.
- Check nutritional intake and other possible causes rather than buying a booster pack.
- Patchy loss, scalp changes or ongoing shedding can need a dermatology assessment.
Avoid a single-cause explanation
Diffuse shedding can occur after physiological stress or substantial weight change. Thyroid conditions, nutritional deficiencies, other medicines and unrelated hair disorders can also matter.
Hair loss is reported in relevant product labeling. A label entry and a biological explanation do not tell us which factor caused one person’s symptoms.
Sources: Wegovy prescribing informationZepbound prescribing informationFoundayo prescribing informationNIH: weight-loss dietary supplements
Match testing to the history
Discuss recent weight change, appetite, protein intake, menstrual or other blood loss and scalp symptoms. A clinician can decide whether testing or dermatology referral is appropriate.
High-dose vitamins are not a universal solution. Taking supplements without an identified need can add cost, cause adverse effects or interfere with testing.
Sources: Wegovy prescribing informationZepbound prescribing informationFoundayo prescribing informationNIH: weight-loss dietary supplements
Sources and review boundaries
Source check dates are listed below. First-party pages support descriptions of a service’s public offer; medical references support the educational context. They do not establish an independent clinical audit of a provider. This is general education, not personal medical advice; no named licensed clinical reviewer has reviewed this article.
- Wegovy prescribing informationMedical or regulatory source · Source reviewed ·
- Zepbound prescribing informationMedical or regulatory source · Source reviewed ·
- Foundayo prescribing informationMedical or regulatory source · Source reviewed ·
- NIH: weight-loss dietary supplementsMedical or regulatory source · Source reviewed ·
Related Articles
GLP-1 medicines before surgery: what to tell the anesthesia team
Tell the anesthesia and procedural team about GLP-1 use early. Current multisociety guidance calls for an individualized plan rather than a blanket stop rule.
What to do when a GLP-1 shipment arrives warm
If an injectable medicine arrives warm, damaged or without clear instructions, contact the pharmacy before using it. The product and actual shipping conditions matter.
Alcohol on semaglutide: risks and questions for your prescriber
There is no alcoholic drink proven safest on a GLP-1. Alcohol can complicate nausea, hydration, blood sugar and the health conditions being treated.
Alcohol on tirzepatide: risks and questions for your prescriber
There is no alcoholic drink proven safest on a GLP-1. Alcohol can complicate nausea, hydration, blood sugar and the health conditions being treated.
Semaglutide compounding pharmacies: sourcing, rules and open questions
Compounded semaglutide and tirzepatide are not FDA-approved. Resolved shortages changed the basis for routine copies, and a pharmacy registration is not approval of its product.
Tirzepatide compounding pharmacies: sourcing, rules and open questions
Compounded semaglutide and tirzepatide are not FDA-approved. Resolved shortages changed the basis for routine copies, and a pharmacy registration is not approval of its product.
By Chief Medical Correspondent. Original publication date was not recorded. Updates are recorded when content changes.